HomeOpen Access NewsDrug Development

Drug Development

Subscribe to Updates

University of Surrey joins global project to create immune digital twins

Pharma
Researchers at the University of Surrey are creating immune digital twins, virtual models of individual immune systems, to advance personalised medicine and deliver tailored treatments.

IDEAS: improving design, evaluation and analysis of early drug development studies

Health & Social Care
Prof Thomas Jaki from the Medical and Pharmaceutical Statistics Research Unit at Lancaster University explores a novel approach to Ph.D. training for those in the pharmaceutical industry

An international approach to the anti-infectives challenge

Research & Innovation
Professor Colin Suckling from the University of Strathclyde discusses the need for global collaboration on the anti-infectives challenge.

Living with Leukaemia

Health & Social Care
Bethany Torr, campaigns and advocacy officer at Leukaemia Care introduces ‘Leukaemia’ and its different forms and explains how people live with the disease Leukaemia’ is...

Early stage diagnosis – spotting early stage cancer events

Cancer Research
Cecilia Van Cauwenberghe, Vandana Iyer and Bhargav Rajan from Frost & Sullivan examine of how nanotechnology helps spot early stage cancer

Treatments and symptoms of Parkinson’s

Health & Social Care
Prof. David Dexter, deputy director of research at Parkinson’s UK shares his thoughts on the symptoms of Parkinson’s and the chances of finding a cure

Publishing national chemotherapy data

Health & Social Care
Publishing national chemotherapy data has helped NHS hospitals make changes that should improve treatment, as Emma Saxon reveals in this article

Chemical biology: A chance conversation but an important question

Health & Social Care
Research professor Prof Colin J Suckling OBE DSc FRSE discusses his engagement with medicinal chemistry and chemical biology

Photodynamic Therapy – radiotherapy for the 21st Century

Health & Social Care
Photodynamic Therapy is a treatment that combines a photosensitizing drug, visible light and oxygen to kill cancer cells. Professor Eli Glatstein explains

What is the European drug situation in 2017?

Health & Social Care
Jane Mounteney, Alexis Goosdeel and Paul Griffiths from the EMCDDA highlight key findings from the 2017 European Drug Report and new threats emerging.

Parasitic infection: Animal health matters too

Health & Social Care
Professor Colin J Suckling explains how teams at the University of Strathclyde and University of Glasgow are challenging global parasitic infection Cows, horse, camels When people...

The evolution of malaria drug development

Research & Innovation
David H Peyton at Portland State University outlines how research has discovered that heme is key to malaria drug development

Identifying novel biomarkers for drug-induced kidney injury

Health & Social Care
The European Federation of Pharmaceutical Industries and Associations (EFPIA) explain how SAFE-T DIKI is advancing research into drug-induced kidney injury

Drug development for cancer and inflammatory disease

Health & Social Care
Sumith A Kularatne, Vice President of Research and Development at On Target Laboratories shares the research strides he has made in drug development

Predicting drug responses

Health & Social Care
Luminex xTAG® CYP2D6 Kit v3 and xTAG® CYP2C19 Kit v3 assays may aid in determining therapeutic strategies for drugs metabolized by CYP2D6 and CYP2C19...

The role of chemistry in drug discovery and development

Research & Innovation
Sriram Radhakrishnan, Healthcare Analyst at Frost & Sullivan details the vital role chemistry plays in drug discovery and development Drug discovery and development is one...

Advertisements


Latest Academic Articles

The latest academic articles from key research stakeholders

Visit Article Archive
Open Access Government

Open Access Government produces compelling and informative news, publications, eBooks, and academic research articles for the public and private sector looking at health, diseases & conditions, workplace, research & innovation, digital transformation, government policy, environment, agriculture, energy, transport and more.

Follow Us

Resources

Quick Links

Legal & Marketing

As a Crossref Sponsored Member we are able to connect your content with a global network of online scholarly research, currently over 20,000 other organizational members from 160 countries. Crossref drive metadata exchange and support nearly 2 billion monthly API queries, facilitating global research communication.

© Adjacent Digital Politics Ltd